Dr. Matei is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
303 E Superior Lurie 4-107
Chicago, IL 60610Phone+1 312-503-4853
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1997 - 1999
- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1993 - 1996
- Carol Davila University of Medicine and PharmacyClass of 1992
Certifications & Licensure
- CA State Medical License 1996 - Present
- IL State Medical License 2015 - 2026
- IN State Medical License 2002 - 2017
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2021 Mar 16
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 74 citationsEpigenetic therapies for chemoresensitization of epithelial ovarian cancerDaniela Matei, Kenneth P. Nephew
Gynecologic Oncology. 2010-02-01 - 83 citationsActivity of 2 methoxyestradiol (Panzem® NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: A Hoosier Oncology Group trialDaniela Matei, Jeanne M. Schilder, Gregory P. Sutton, Susan M. Perkins, Tim Breen
Gynecologic Oncology. 2009-10-01 - 115 citationsFrizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.Yinu Wang, Guangyuan Zhao, Salvatore Condello, Hao Huang, Horacio Cardenas
Cancer Research. 2021-01-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: